Hemoglobin catabolism and iron utilization by malaria parasites

Molecular and Biochemical Parasitology

Volumn 83, Issue 2, 1996, Pages 131-139

  Rosenthal, Philip J ^a,c   Meshnick, Steven R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ar temisinin; chelator; chloroquine; erythrocyte; heme; hemozoin; Plasmodium; protease; quinoline

Indexed keywords

ARTEMISININ; CHLOROQUINE; HEME; HEMOGLOBIN; HEMOZOIN; IRON; PROTEINASE; QUINOLINE;

BIODEGRADATION; CATABOLISM; ERYTHROCYTE; HUMAN; MALARIA; NONHUMAN; PLASMODIUM; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIMALARIALS; HEMOGLOBINS; IRON; PLASMODIUM;

EID: 0030596209     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(96)02763-6     Document Type: Review

References (77)

1. [1] Sherman, I.W. (1979) Biochemistry of Plasmodium (malarial parasites). Microbiol. Rev. 43, 453-495.
2. [2] Scheitel, L.W. and Sherman, I.W. (1988) Plasmodial metabolism and related organellar function during various stages of the life-cycle: proteins, lipids, nucleic acids and vitamins. In: Malaria: Principles and Practice of Malariology (Wernsdorfer, W.H. and McGregor, I., eds.), pp. 219-252. Churchill Livingstone, Edinburgh.
3. [3] McKerrow, J.H., Sun, E., Rosenthal, P.J. and Bouvier, J. (1993) The proteases and pathogenicity of parasitic protozoa. Annu. Rev. Microbiol. 47, 821-853.
4. [4] Francis, S.E., Gluzman, I.Y., Oksman, A., Knickerbocker, A., Mueller, R., Bryant, M.L., Sherman, D.R., Russell, D.G. and Goldberg, D. E. (1994) Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase. EMBO J. 13, 306-317.
5. [5] Rosenthal, P.J., McKerrow, J.H., Aikawa, M., Nagasawa, H. and Leech, J.H. (1988) A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum. J. Clin. Invest. 82, 1560-1566.
6. [6] Rosenthal, P.J. (1995) Plasmodium falciparum: Effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites. Exp. Parasitol. 80, 272-281.
7. [7] Rubin, H., Salem, J.S., Li, L.-S., Yang, F., Mama, S., Wang, Z., Fisher, A., Hamann, C.S. and Cooperman, B.S. (1993) Cloning, sequence determination, and regulation of the ribonucleotide reductase subunits from Plasmodium falciparum: a target for antimalarial therapy. Proc. Natl. Acad. Sci. USA 90, 9280-9284.
8. [8] Becuwe, P., Gratepanche, S., Fourmaux, M.N., Van Beeumen, J., Samyn, B., Mercereau-Puijalon, O., Touzel, J.P., Slomianny, C., Camus, D. and Dive, D. (1996) Characterization of iron-dependent endogenous superoxide dismutase of Plasmodium falciparum. Mol. Biochem. Parasitol. 76, 125-134.
9. [9] Fry, M. and Beesley, J.E. (1991) Mitochondria of mammalian Plasmodium spp. Parasitology 102, 17-26.
10. [10] Surolia, N. and Padmanaban, G. (1992) De novo biosynthesis of heme offers a new chemotherapeutic target in the human malarial parasite. Biochem. Biophys. Res. Commun. 187, 744-750.
11. [11] Wilson, C.M., Smith, A.B. and Baylon, R.V. (1996) Characterization of the δ-aminolevulinate synthase gene homolog in P. falciparum. Mol. Biochem. Parasitol. 75, 271-275.
12. [12] Gordeuk, V.R., Thuma, P.E. and Brittenham, G.M. (1994) Iron chelation therapy for malaria. Adv. Exp. Med. Biol. 356, 371-383.
13. [13] Sanchez-Lopez, R. and Haldar, K. (1992) A transferrin-independent iron uptake activity in Plasmodium falciparum-infected and uninfected erythrocytes. Mol. Biochem. Parasitol. 55, 9-20.
14. [14] Oppenheimer, S.J., Gibson, F.D., Macfarlane, S.B., Moody, J.B., Harrison, C., Spencer, A. and Bunari, O. (1986) Iron supplementation increases prevalence and effects of malaria: report on clinical studies in Papua New Guinea. Trans. R. Soc. Trop. Med. Hyg. 80, 603-612.
15. [15] Peto, T.E.A. and Thompson, J.L. (1986) A reappraisal of the effects of iron and desferrioxamine on the growth of Plasmodium falciparum in vitro: the unimportance of serum iron. Br. J. Haematol. 63, 273-280.
16. [16] Pollack, S. and Schnelle, V. (1988) Inability to detect transferrin receptors on P. falciparum parasitized red cells. Br. J. Haematol. 68, 125-129.
17. [17] Scott, M.D., Ranz, A., Kuypers, F.A., Lubin, B.H. and Meshnick, S.R. (1990) Parasite uptake of desferroxamine: a prerequisite for antimalarial activity. Br. J. Haematol. 75, 598-602.
18. [18] Hershko, C. and Peto, T.E.A. (1988) Deferoxamine inhibition of malaria is independent of host iron status. J. Exp. Med. 168, 375-387.
19. [19] Harvey, P.W.J., Heywood, P.P., Nesheim, M.C., Galme, K., Zegans, M., Habicht, J.-P., Stephenson, L.S., Radimer, K.L., Brabin, B., Forsyth, K. and Alpers, M.P. (1989) The effect of iron therapy on malarial infection in Papua New Guinean schoolchildren. Am. J. Trop. Med. Hyg. 40, 12-18.
20. [20] Loyevsky, M., Lytton, S.D., Mester, B., Libman, J., Shanzer, A. and Cabantchik, Z.I. (1993) The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites. J. Clin. Invest. 91, 218-224.
21. [21] Gabay, T. and Ginsburg, H. (1993) Hemoglobin denaturation and iron release in acidified red blood cell lysate -a possible source of iron for intraerythrocytic malaria parasites. Exp. Parasitol. 77, 261-272.
22. [22] Yayon, A., Vande Waa, J.A., Yayon, M., Geary, T.G. and Jensen, J.B. (1983) Stage-dependent effects of chloroquine on Plasmodium falciparum in vitro. J. Protozool. 30, 642-647.
23. [23] Olliaro, P.L. and Goldberg, D.E. (1995) The Plasmodium digestive vacuole: metabolic headquarters and choice drug target. Parasitol. Today 11, 294-297.
24. [24] Slomianny, C. (1990) Three-dimensional reconstruction of the feeding process of the malaria parasite. Blood Cells 16, 369-378.
25. [25] Yayon, A., Cabantchik, Z.I. and Ginsburg, H. (1984) Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine. EMBO J. 3, 2695-2700.
26. [26] Krogstad, D.J., Schlesinger, P.H. and Gluzman, I.Y. (1985) Antimalarials increase vesicle pH in Plasmodium falciparum. J. Cell Biol. 101, 2302-2309.
27. [27] Krogstad, D.J. and Schlesinger, P.H. (1987) Acid-vesicle function, intracellular pathogens, and the action of chloroquine against Plasmodium falciparum. New Engl. J. Med. 317, 542-549.
28. [28] Goldberg, D.E., Slater, A.F.G., Cerami, A. and Henderson, G.B. (1990) Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle. Proc. Natl. Acad. Sci. USA 87, 2931-2935.
29. [29] Choi, I. and Mego, J.L. (1988) Purification of Plasmodium falciparum digestive vacuoles and partial characterization of the vacuolar membrane ATPase. Mol. Biochem. Parasitol. 31, 71-78.
30. [30] Dominguez, N.D.G. and Rosenthal, P.J. (1996) Cysteine proteinase inhibitors block early steps in hemoglobin degradation by cultured malaria parasites. Blood 87, 4448-4454.
31. [31] Asawamahasakda, W., Ittarat, I., Chang, C.-C., McElroy, P. and Meshnick, S.R. (1994) Effects of antimalarials and protease inhibitors on plasmodial hemozoin production. Mol. Biochem. Parasitol. 67, 183-191.
32. [32] Rosenthal, P.J. and Nelson, R.G. (1992) Isolation and characterization of a cysteine proteinase gene of Plasmodium falciparum. Mol. Biochem. Parasitol. 51, 143-152.
33. [33] Gluzman, I.Y., Francis, S.E., Oksman, A., Smith, C.E., Duffin, K.L. and Goldberg, D.E. (1994) Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. J. Clin. Invest. 93, 1602-1608.
34. [34] Goldberg, D.E., Slater, A.F.G., Beavis, R., Chait, B., Cerami, A. and Henderson, G.B. (1991) Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease. J. Exp. Med. 173, 961-969.
35. [35] Vander Jagt, D.L., Hunsaker, L.A., Campos, N.M. and Scaletti, J.V. (1992) Localization and characterization of hemoglobin-degrading aspartic proteinases from the malarial parasite Plasmodium falciparum. Biochim. Biophys. Acta 1122, 256-264.
36. [36] Dame, J.B., Reddy, G.R., Yowell, C.A., Dunn, B.M., Kay, J. and Berry, C. (1994) Sequence, expression and modeled structure of an aspartic proteinase from the human malaria parasite Plasmodium falciparum. Mol. Biochem. Parasitol. 64, 177-190.
37. [37] Hill, J., Tyas, L., Phylip, L.H., Kay, J., Dunn, B.M. and Berry, C. (1994) High level expression and characterisation of plasmepsin II, an aspartic proteinase from Plasmodium falciparum. FEBS Lett. 352, 155-158.
38. [38] Salas, F., Fichmann, J., Lee, G.K., Scott, M.D. and Rosenthal, P.J. (1995) Functional expression of falcipain, a Plasmodium falciparum cysteine proteinase, supports its role as a malarial hemoglobinase. Infect. Immun. 63, 2120-2125.
39. [39] Dluzewski, A.R., Rangachari, K., Wilson, R.J.M. and Gratzer, W.B. (1986) Plasmodium falciparum: protease inhibitors and inhibition of erythrocyte invasion. Exp. Parasitol. 62, 416-422.
40. [40] Bailly, E., Jambou, R., Savel, J. and Jaureguiberry, G. (1992) Plasmodium falciparum: differential sensitivity in vitro to E-64 (cysteine protease inhibitor) and pepstatin A (aspartyl protease inhibitor). J. Protozool. 39, 593-599.
41. [41] Orjih, A.U., Banyal, H.S., Chevli, R. and Fitch, C.D. (1981) Hemin lyses malaria parasites. Science 214, 667-669.
42. [42] Wood, P.A. and Eaton, J.W. (1993) Hemoglobin catabolism and host-parasite heme balance in chloroquine-sensitive and chloroquine-resistant Plasmodium berghei infections. Am. J. Trop. Med. Hyg. 48, 465-472.
43. [43] Slater, A.F.G., Swiggard, W.J., Orton, B.R., Flitter, W.D., Goldberg, D.E., Cerami, A. and Henderson, G.B. (1991) An iron-carboxylate bond links the heme units of malaria pigment. Proc. Natl. Acad. Sci. U.S.A. 88, 325-329.
44. [44] Warhurst, D.C. (1995) Hemozoin and the mode of action of blood schizontocides: more controversy. Parasitol. Today 11, 204-205.
45. [45] Fitch, C.D. and Kanjananggulpan, P. (1987) The state of ferriprotoporphyrin IX in malaria pigment. J. Biol. Chem. 262, 15552-15555.
46. [46] Ashong, J.O., Blench, I.P. and Warhurst, D.C. (1989) The composition of haemozoin from Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 83, 167-172.
47. [47] Goldie, P., Roth, E.F., Oppenheim, J. and Vanderberg, J.P. (1990) Biochemical characterization of Plasmodium falciparum hemozoin. Am. J. Trop. Med. Hyg. 43, 584-596.
48. [48] Slater, A.F.G. and Cerami, A. (1992) Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature 355, 167-169.
49. [49] Egan, T.J., Ross, D.C. and Adams, P.A. (1994) Quinoline anti-malarial drugs inhibit spontaneous formation of β-haematin (malaria pigment). FEBS Lett. 352, 54-57.
50. [50] Dorn, A., Stoffel, R., Matile, H., Bubendorf, A. and Ridley, R.G. (1995) Malarial haemozoin/β-haematin supports haem polymerization in the absence of protein. Nature 374, 269-271.
51. [51] Bendrat, K., Berger, B.J. and Cerami, A. (1995) Haem polymerization in malaria. Nature 378, 138.
52. [52] Sullivan, D.J., Gluzman, I.Y. and Goldberg, D.E. (1996) Plasmodium hemozoin formation mediated by histidinerich proteins. Science 271, 219-222.
53. [53] Theil, E.C. (1994) Iron regulatory elements (IREs): a family of mRNA non-coding sequences. Biochem. J. 304, 1994.
54. [54] Reddy, G.R. (1995) Determining the sequence of parasite DNA. Parasitol. Today 11, 37-42.
55. [55] Meshnick, S.R. and Marr, J.J. (1992) Intracellular parasites: new developments in chemotherapy. Subcell. Biochem. 18, 401-441.
56. [56] Surolia, N. and Padmanaban, G. (1991) Chloroquine inhibits heme-dependent protein synthesis in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 88, 4786-4790.
57. [57] Gabay, T., Krugliak, M., Shalmiev, G. and Ginsburg, H. (1994) Inhibition by anti-malarial drugs of haemoglobin denaturation and iron release in acidified red blood cell lysates - a possible mechanism of their anti-malarial effect?. Parasitology 108, 371-381.
58. [58] Fitch, C.D., Chevli, R., Banyal, H.S., Phillips, G., Pfaller, M.A. and Krogstad, D.J. (1982) Lysis of Plasmodium falciparum by ferriprotoporphyrin IX and a chloroquine-ferriprotoporphyrin IX complex. Antimicrob. Agents Chemother. 21, 819-822.
59. 3H]chloroquine by drug-sensitive and -resistant strains of the human malaria parasite Plasmodium falciparum. Biochem. Pharmacol. 35, 3805-3812.
60. [60] Orjih, A.U. and Fitch, C.D. (1993) Hemozoin production by Plasmodium falciparum: variation with strain and exposure to chloroquine. Biochim. Biophys. Acta 1157, 270-274.
61. [61] Orjih, A.U., Ryerse, J.S. and Fitch, C.D. (1994) Hemoglobin catabolism and the killing of intraerythrocytic Plasmodium falciparum by chloroquine. Experientia 50, 34-39.
62. [62] Meshnick, S.R., Taylor, T.E. and Kamchonwongpaisan (1996) Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol. Rev. 60, 301-315.
63. [63] Brossi, A., Venugopalan, B., Doninguez Gerpe, L., Yeh, H.J.C., Flippen-Anderson, J.L., Buchs, P., Luo, X.-D., Milhous, W. and Peters, W. (1988) Arteether, a new antimalarial drug: synthesis and antimalarial properties. J. Med. Chem. 31, 645-650.
64. [64] Meshnick, S.R., Yang, Y.-Z., Lima, V., Kuypers, F., Kamchonwongpaisan, S. and Yuthavong, Y. (1993) Iron-dependent free radical generation and the antimalarial artemisinin (qinghaosu). Antimicrob. Agents Chemother. 37, 1108-1114.
65. [65] Hong, Y.-L., Yang, Y.-Z. and Meshnick, S.R. (1994) The interaction of artemisinin with malarial hemozoin. Mol. Biochem. Parasitol. 63, 121-128.
66. [66] Cumming, J.N., Ploypradith, P. and Posner, G. (In Press) Malaria chemotherapy using 1,2,4-trioxanes related to artemisinin: molecular mechanism(s) of action. Adv. Pharmacol.
67. [67] Asawamahasakda, W., Ittarat, I., Pu, Y.-M., Ziffer, H. and Meshnick, S.R. (1994) Alkylation of parasite-specific proteins by endoperoxide antimalarials. Antimicrob. Agents Chemother. 38, 1854-1858.
68. [68] Lytton, S., Cabantchik, Z., Libman, J. and Shanzer, A. (1991) Reversed siderophores as antimalarial agents. II. Selective scavenging of Fe(III) from parasitized erythrocytes by a fluorescent derivative of desferal. Mol. Pharmacol. 40, 584-590.
69. [69] Gordeuk, V., Thuma, P., Brittenham, G., McLaren, C., Parry, D., Backenstose, A., Biemba, G., Msiska, R., Holmes, L., McKinley, E., Vargas, L., Gilkeson, R. and Poltera, A.A. (1992) Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N. Engl. J. Med. 327, 1473-1477.
70. [70] Sullivan, A.D., Ittarat, I. and Meshnick, S.R. (1996) Patterns of hemozoin accumulation in tissue. Parasitology 112, 285-294.
71. [71] Scheibel, L.W. (1984) In vitro inhibition of the human malaria parasite by selected lipophilic chelators. Prog. Clin. Biol. Res. 165, 377-394.
72. [72] Cabantchik, Z.I. (1995) Iron chelators as antimalarials: the biochemical basis of selective cytotoxicity. Parasitol. Today 11, 74-78.
73. [73] Rosenthal, P.J., Wollish, W.S., Palmer, J.T. and Rasnick, D. (1991) Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase. J. Clin. Invest. 88, 1467-1472.
74. [74] Rosenthal, P.J., Olson, J.E., Lee, G.K., Palmer, J.T., Klaus, J.L. and Rasnick, D. (1996) Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors. Antimicrob. Agents Chemother. 40, 1600-1603.
75. [75] Rosenthal, P.J., Lee, G.K. and Smith, R.E. (1993) Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria. J. Clin. Invest. 91, 1052-1056.
76. [76] Ring, C.S., Sun, E., McKerrow, J.H., Lee, G.K., Rosenthal, P.J., Kuntz, I.D. and Cohen, F.E. (1993) Structure-based inhibitor design by using protein models for the development of antiparasitic agents. Proc. Natl. Acad. Sci. USA 90, 3583-3587.
77. [77] Li, R., Kenyon, G.L., Cohen, F.E., Chen, X., Gong, B., Dominguez, J.N., Davidson, E., Kurzban, G., Miller, R.E., Nuzum, E.O., Rosenthal, P.J. and McKerrow, J.H. (1995) In vitro antimalarial activity of chalcones and their derivatives. J. Med. Chem. 38, 5031-5037.